Shared Solutions®:
Where a diversity of symptoms and lifestyle converge to create more solutions.
Welcome to a caring network of support for those living with and
touched by relapsing-remitting multiple sclerosis (RRMS). After 10-plus
years of listening to and learning from the MS community, Shared Solutions® and COPAXONE® are happy to now offer you more: More information, more inspiration, more therapy tools, more lifestyle stories and more overall support. Right here. In this site.
Read more about Shared Solutions®
Suggested articles
Portraits of MS
10 tips for CarePartners
Active nutrition: Ways to get both
You, your MS & everyone else
Need injection assistance?
Watch a video demonstration.
Hear about in-home training.
Download an injection guide.
Call a Shared Solutions® MS-trained nurse at
1-800-887-8100
- COPAXONE® (glatiramer acetate injection) is indicated
for the reduction of the frequency of relapses in relapsing-remitting
multiple sclerosis, including patients who have experienced a first
clinical episode and have MRI features consistent with multiple
sclerosis.
Important Safety Information About COPAXONE®
- The most common side effects of COPAXONE® are
redness, pain, swelling, itching, or a lump at the site of injection,
flushing, rash, shortness of breath, and chest pain. These reactions are
usually mild and seldom require professional treatment. Be sure to tell
your doctor about any side effects.
Some patients report a short-term reaction right after injecting COPAXONE®.
This reaction can involve flushing (feeling of warmth and/or redness),
chest tightness or pain with heart palpitations, anxiety, and trouble
breathing. These symptoms generally appear within minutes of an
injection, last about 15 minutes, and go away by themselves without
further problems.
A permanent indentation under the skin at the injection site may
occur, due to a local destruction of fat tissue. Be sure to follow
proper injection technique and inform your doctor of any skin changes.
After you inject COPAXONE®, call your doctor right away
if you develop hives, skin rash with irritation, dizziness, sweating,
chest pain, trouble breathing, severe pain at the injection site or
other uncomfortable changes in your general health. Do not give yourself
any more injections until your doctor tells you to begin again.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
*IMS Health National Prescription Audit, May 2011. Data is proprietary to IMS Health.
†Certain limits and restrictions apply.
Terms and Conditions: COPAXONE Co-pay Solutions™
is open to both new and existing patients who are residents of the US or Puerto
Rico and who have private insurance coverage. The offer is not valid for
patients covered in whole or in part by Medicaid, Medicare, TRICARE, or any
other federal or state government pharmaceutical assistance plan or program
(regardless of whether a specific prescription is covered), or by private
health benefit programs that reimburse for the entire cost of prescription
drugs. Use of this offer must be consistent with the terms of any drug
benefit provided by a health insurer, health plan, or private third-party
payor. This offer is void in Massachusetts or where otherwise prohibited by
law, taxed, or restricted. No additional purchase is required. This offer
is valid only at participating pharmacies and may be changed or discontinued
at any time without notice. This program is not health insurance.
COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered trademark of Teva Neuroscience, Inc. autoject®2 for glass syringe
is a registered trademark of Owen Mumford, Ltd. COPAXONE CO-PAY SOLUTIONS™ is a trademark of Teva Pharmaceutical Industries Ltd. © 2011, Teva
Neuroscience, Inc. All Rights Reserved. This site is intended for US
residents only.
The brands listed are the trademarks and registered trademarks of their respective owners.